Blood Glucose Monitoring Devices Market Research Report covers the present scenario and the growth prospects of the Blood Glucose Monitoring Devices Industry for 2017-2021. Blood Glucose Monitoring Devices Market, has been prepared based on an in-depth market analysis with inputs from industry experts.
The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Blood Glucose Monitoring Devices globally.
For further information on this report, please visit- http://www.marketreportsworld.com/10355580
The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Blood Glucose Monitoring Devices Market:
- Abbott Laboratories
- Roche Diagnostics
Other Prominent Vendors of Blood Glucose Monitoring Devices Market Are:
- Becton Dickinson
- Bioptik Technology
- Integrity Applications
- International Biomedical
- Menarini Diagnosticos
- Nipro Diagnostics
- Nova Biomedical
- Owen Mumford
- TaiDoc Technology
One trend in market is smart watch-based apps. The Dexcom CGM and its mobile apps Follow and Share 2 are the first mobile-connected systems approved by the US FDA. This device allows users to directly view the glucose data on their iPhone. Currently, Dexcom provides its devices G4 platinum CGM with Share that supports the Apple watch. Along with this, the users can invite up to five people to view their glucose information, and an alert message can be sent when the user’s glucose levels are above normal range. This is a significant breakthrough in diabetes management. The use of glucose meters is supplemented by CGM devices in diabetes management. Meters still play a major role in calibrating CGM devices and in guiding therapy and meal decisions. In addition to providing the glucose levels, CGM devices provide the direction and rate of change in glucose levels with the push of a button and alerts users when the glucose level is too low or too high.
Ask Sample PDF of Blood Glucose Monitoring Devices Market Report @ http://www.marketreportsworld.com/enquiry/request-sample/10355580
According to the report, one driver in market is growing prevalence of diabetes in the world. In 2015, approximately 415 million people in the world had diabetes, which is expected to increase to around 642 million by 2040. As of 2015, it has been estimated that 9.1% adults in the world have diabetes and this is expected to increase to 10% by 2040. In addition, 75%-80% of the individuals with diabetes belonged to low- and middle-income countries. The number of people with diabetes is high in APAC. According to OECD, the prevalent cases are going to reach about 47,973,000 in Europe, 66,812,000 in the Americas, and 18,234,000 in Africa by 2030. The global prevalence of diabetes was estimated to be 9% among adults aged above 18 years.
Report also presents Geographical Segmentation analysis of Blood Glucose Monitoring Devices Market of Americas, APAC, EMEA region.
For Any Query, Contact Our Expert @ http://www.marketreportsworld.com/enquiry/pre-order-enquiry/10355580
Further, the report states that one challenge in market is high cost of BGM devices. The high cost of BGM devices is a major challenge hindering the growth of the global BGM devices market. Most invasive BGM devices are both painful as they use a lancet to prick the fingertip to extract blood required for testing. They are also expensive due to the consumable test strips that are needed to test the blood. So, many diabetic patients are reluctant to adopt BGM devices and do not monitor their blood glucose levels as often as they should. Moreover, calibration of the BGM systems is also very expensive. So, despite the numerous benefits, the high cost of BGM devices hinders their acceptance among patients. The average price of lancing devices ranges from $30 to $35 in most countries.
Key questions answered in Blood Glucose Monitoring Devices market report:
- What will the Blood Glucose Monitoring Devices market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving Blood Glucose Monitoring Devices market?
- What are the challenges to Blood Glucose Monitoring Devices market growth?
- Who are the key vendors in Blood Glucose Monitoring Devices market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
No of Pages: 86
Price of Report: $ 3500 (Single User License)
Purchase Report @ http://www.marketreportsworld.com/purchase/10355580
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Mr. Ameya Pingaley
Market Reports World
+1 408 520 9750
Email – firstname.lastname@example.org